Firms
Theme

SYK

Stryker Corporation · NYSE

$307.15USDCS band Mixed

↑ $0.07 (0.02%)

Last close · Oct 23, 4:00 PM ET

Sign up free to see this.

Mkt Cap
$117.8B
Volume
1.4M
52W High
$389.33
52W Low
$267.00
PE Ratio
31.6
Avg Vol
2.7M
As of 10/23/26
Div Yield
1.12%
Beta
0.10
As of 10/23/26

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Sentiment

No sentiment yet

At least 5 tagged posts are needed.

How do you feel about SYK?

Latest news

News ›

Zacks Investment Research

2 Industries Beyond AI With Long-Term Demand Drivers for 2027

As AI dominates investment focus, healthcare and waste management sectors offer alternative diversification opportunities. Healthcare benefits from an aging population and rising medical needs, while waste management provides recurring revenue from essential services. Key companies like Abbott, Johnson & Johnson, Stryker, Waste Management, and Republic Services are positioned to capitalize on these structural trends.

Zacks Investment Research

Stryker Enters Soft-Tissue Robotics With $400 Million CMR Deal

Stryker announced a $400 million preferred equity investment in CMR Surgical, gaining exclusive U.S. sales rights for the Versius robotic surgery platform and an option to acquire the company. The deal allows Stryker to expand into soft-tissue robotics, complementing its existing Mako orthopedic platform, while CMR Surgical retains global commercialization rights outside the U.S.

GlobeNewswire Inc.

Australia Stretchers and Cots Market Outlook to 2033 - Revenue, Volume, Pricing and Company Share Forecast | Segment Growth Opens Investment and Expansion Opportunities

ResearchAndMarkets.com released a comprehensive market report on Australia's stretchers and cots sector, covering ambulance cots, emergency stretchers, manual and motorized transport stretchers through 2033. The report provides revenue forecasts, volume data, pricing analysis, and competitive landscape insights for manufacturers, healthcare suppliers, and investors. Key companies analyzed include Stryker Corp, Hill-Rom Holdings Inc, International Biomedical Ltd, and Linet Group SE.

Headlines link to the publisher. Not investment advice.

Board · 0 threads

Open board ›

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $SYK · 0 threads

Sign in to post on $SYK

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev